PUBLISHER: IMARC | PRODUCT CODE: 1722463
PUBLISHER: IMARC | PRODUCT CODE: 1722463
Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033
The global biotechnology market size reached USD 761.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1,315.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. The increasing research and development (R&D) in personalized medicine, numerous advancements in genetic engineering, and escalating demand for sustainable agriculture are some of the major factors propelling the market.
Biotechnology is a multidisciplinary field that encompasses the use of living organisms, cells, and biological systems to develop innovative products and technologies. It involves harnessing biological processes and organisms at the molecular and cellular level to address various challenges across industries, such as healthcare, agriculture, and environmental management. Biotechnology includes areas like genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology, all aimed at creating new solutions, improving existing processes, and advancing our understanding of living systems. This field plays a crucial role in shaping modern medicine, sustainable agriculture, and the development of novel materials for diverse applications.
The rising innovation in areas, including gene editing, personalized medicine, and novel therapies, due to rapid advancements in genetic research and the understanding of molecular biology, will stimulate the market growth during the forecast period. Moreover, the increasing prevalence of chronic diseases and the need for targeted treatments have augmented the demand for biopharmaceuticals and precision medicine, thus positively influencing the market growth. Additionally, the heightening demand for sustainable agricultural solutions owing to the expanding global population and limited arable land has accelerated the adoption of biotechnological techniques in crop improvement and biopesticides. Apart from this, the convergence of biotechnology with information technology, known as bioinformatics, that enhances data-driven insights for research and development is propelling the market growth. Furthermore, the development of bioremediation methods and biofuels on account of the escalating focus on environmental sustainability is contributing to market growth.
Biotechnology Market Trends/Drivers:
Rapid advancements in genetic engineering
The remarkable progress in genetic engineering, prominently exemplified by the revolutionary CRISPR-Cas9 technology, represents a primary driver in the biotechnology market. This technique allows scientists to precisely modify genes within organisms, presenting unprecedented potential for applications in medicine, agriculture, and industrial processes. In healthcare, genetic engineering facilitates the development of innovative gene therapies for genetic disorders and cancers, offering promising avenues for personalized treatments. Moreover, the ability to engineer microbes for the production of valuable compounds like insulin and enzymes has transformed pharmaceutical and industrial manufacturing.
Increasing demand for personalized medicine and therapeutics
The concept of personalized medicine, tailored to an individual's genetic makeup, is gaining traction in the biotechnology market. Advancements in genomic sequencing technologies have made it possible to analyze an individual's genetic code and identify genetic variations linked to diseases. This has led to the development of targeted therapies that address the unique genetic characteristics of patients, enhancing treatment efficacy and reducing adverse effects. Biotechnology enables the production of biopharmaceuticals such as monoclonal antibodies and gene therapies, aligning with the principles of personalized medicine. Additionally, diagnostics based on genetic markers allow for early disease detection and prognosis, reshaping healthcare practices toward more precise and individualized approaches.
Rising need for sustainable agriculture solutions
The increasing global demand for food, coupled with environmental concerns and the need for sustainable agricultural practices, fuels the adoption of biotechnological solutions in farming. Genetically modified crops (GMOs) engineered for enhanced yield, pest resistance, and nutritional content are examples of biotechnology's influence on agriculture. Biopesticides derived from naturally occurring organisms are gaining preference over traditional chemical pesticides owing to their reduced environmental impact. Biotechnology offers tools to optimize plant traits, improve crop resilience to climate change, and increase nutrient efficiency, contributing to food security and resource sustainability. This driver reflects the critical role of biotechnology in addressing pressing challenges within the agriculture sector while minimizing ecological footprints.
Biotechnology Industry Segmentation:
Breakup by Product Type:
- Instruments
- Reagents
- Software and Services
Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation. Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs. Software plays a pivotal role, providing data analysis, visualization, and integration solutions, enhancing efficiency and accuracy in biotechnological endeavors. Services encompass consulting, training, and technical support, nurturing collaboration and aiding in the effective utilization of tools.
Furthermore, these components synergistically push the boundaries of biotechnology, fostering innovation and driving advancements that impact diverse sectors such as healthcare, agriculture, and environmental sciences. As the industry evolves, the strategic interplay of instruments, reagents, software, and services continues to shape the trajectory of biotechnology, fueling growth, discovery, and progress.
Breakup by Technology:
- Nanobiotechnology
- Tissue Engineering and Regeneration
- DNA Sequencing
- Cell-Based Assays
- Fermentation
- PCR Technology
- Chromatography
- Others
Nanobiotechnology integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies. Tissue engineering and regeneration pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs. DNA sequencing enables comprehensive genomic analysis, guiding personalized medicine and disease understanding. Cell-based assays provide insights into cellular behavior, supporting drug development and toxicity testing. Fermentation is a cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes. PCR Technology amplifies DNA, underpinning diagnostics and genetic research.
Chromatography separates biomolecules with precision, crucial in drug purification and analytical processes. These intertwined advancements drive the market's progress, fostering innovation and solutions across healthcare, agriculture, and environmental sectors.
Breakup by Application:
- Healthcare
- Food and Agriculture
- Natural Resources and Environment
- Industrial Processing
- Bioinformatics
- Others
Healthcare dominates the market
Healthcare serves as a pivotal driving force behind the biotechnology market, catalyzing innovations that transform patient care and medical practices. Biotechnology solutions play a vital role in diagnostics, treatment development, and personalized medicine. From advanced DNA sequencing enabling precise disease identification to biopharmaceuticals revolutionizing treatment modalities, the synergy between healthcare and biotechnology yields breakthrough therapies, improved patient outcomes, and enhanced disease management.
As healthcare and biotechnology intertwine, novel discoveries in areas such as gene editing, synthetic biology, and biomarker development further propelling the market growth. The biotechnology sector's continual evolution addresses current medical challenges and paves the way for future advancements, shaping the landscape of healthcare delivery and underscoring its significance as a critical driver of progress within the biotechnology domain.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest share in the market since the region boasts a robust ecosystem of research, innovation, and industry collaboration. The region's strong investment in research and development (R&D), coupled with its well-established regulatory frameworks, fosters an environment conducive to biotechnological breakthroughs. Various leading universities, research institutions, and biotech companies converge to push the boundaries of scientific discovery and technological advancements.
Furthermore, the rising emphasis of the North America region on entrepreneurship and venture capital further accelerates the commercialization of novel biotech solutions. With a history of pioneering achievements in areas such as genomics, pharmaceuticals, and medical devices, North America's influential role continues to shape the global biotechnology landscape, catalyzing growth, fostering innovation, and driving positive societal and economic impacts.
Competitive Landscape:
Key players in the biotechnology market have introduced groundbreaking innovations. Leading biopharmaceutical companies are developing mRNA-based vaccines that demonstrated remarkable efficacy in pandemic response. Additionally, advancements in CRISPR-based gene editing techniques have enabled precise and efficient modifications in various organisms, promising transformative applications in genetic therapies and modified crops. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development processes is accelerating the identification of potential drug candidates. These innovations reflect the industry's commitment to addressing global challenges, ranging from disease outbreaks to food security, through cutting-edge biotechnological solutions with the potential to reshape medical treatments, agriculture practices, and industrial processes. We also expect the market to witness new entrants, consolidation of portfolios, and an increase in strategic partnerships and collaborations among vendors to drive healthy competition within the domain during the forecast period.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Amgen Inc.
- Biocon Limited
- Biogen Inc.
- F. Hoffmann-La Roche AG
- Genmab A/S
- Lonza Group AG
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Seagen Inc.
- Syngenta AG
- Vertex Pharmaceuticals Incorporated
Recent Developments:
In May 2022, F. Hoffmann-La Roche Ltd, a leading healthcare enterprise headquartered in Switzerland, introduced the innovative breast cancer antibody cocktail drug, PHESGO, to the Indian market. This breakthrough offering comes with a compelling advantage, as it is not only priced at a remarkable 20% lower than existing therapies but also offers a more streamlined and convenient administration process. It specifically targets HER-2 positive breast cancer, a challenging and prevalent subtype, while holding the distinction of being sanctioned for both early and advanced stages, including metastatic cases.
In January 2021, Novartis AG, a renowned pharmaceutical leader, entered into a strategic collaboration with Alnylam, a pioneering biotechnology company specializing in RNA interference (RNAi) technology. This innovative partnership aims to harness Alnylam's cutting-edge small interfering RNA (siRNA) technology to pave the way for a revolutionary targeted therapy. The focus of this collaboration centers on restoring optimal liver function, a critical aspect in numerous medical conditions.
In Jan 2023, Pfizer Inc., a global leader in biopharmaceuticals, collaborated with Gero, an avant-garde biotechnology company renowned for its advanced technology platform. This strategic research collaboration marks a convergence of expertise and technology, aiming to unlock new insights into the complex realm of fibrotic diseases. By harnessing Pfizer's extensive domain knowledge and Gero's state-of-the-art machine-learning capabilities, the partnership endeavors to chart unexplored territories in the understanding of genes and pathways linked to fibrosis - a group of disorders characterized by tissue scarring and dysfunction.
Key Questions Answered in This Report
- 1.How big is the biotechnology market?
- 2.What is the expected growth rate of the global biotechnology market during 2025-2033?
- 3.What are the key factors driving the global biotechnology market?
- 4.What has been the impact of COVID-19 on the global biotechnology market?
- 5.What is the breakup of the global biotechnology market based on the application?
- 6.What are the key regions in the global biotechnology market?
- 7.Who are the key players/companies in the global biotechnology market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Biotechnology Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Nanobiotechnology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Tissue Engineering and Regeneration
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Cell-Based Assays
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Fermentation
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 PCR Technology
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Chromatography
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 Others
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
8 Market Breakup by Application
- 8.1 Healthcare
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Food and Agriculture
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Natural Resources and Environment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Industrial Processing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Bioinformatics
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Amgen Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.2 Biocon Limited
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Biogen Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche AG
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Genmab A/S
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Lonza Group AG
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Novartis AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Novo Nordisk A/S
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Pfizer Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Regeneron Pharmaceuticals Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Seagen Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Syngenta AG
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 SWOT Analysis
- 14.3.13 Vertex Pharmaceuticals Incorporated
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
- 14.3.1 Amgen Inc.
List of Figures
- Figure 1: Global: Biotechnology Market: Major Drivers and Challenges
- Figure 2: Global: Biotechnology Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Biotechnology Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Biotechnology Market: Breakup by Product Type (in %), 2024
- Figure 5: Global: Biotechnology Market: Breakup by Technology (in %), 2024
- Figure 6: Global: Biotechnology Market: Breakup by Application (in %), 2024
- Figure 7: Global: Biotechnology Market: Breakup by Region (in %), 2024
- Figure 8: Global: Biotechnology (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Biotechnology (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Biotechnology (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Biotechnology (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Biotechnology (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Biotechnology (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Biotechnology (Nanobiotechnology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Biotechnology (Nanobiotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Biotechnology (Tissue Engineering and Regeneration) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Biotechnology (Tissue Engineering and Regeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Biotechnology (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Biotechnology (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Biotechnology (Cell-Based Assays) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Biotechnology (Cell-Based Assays) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Biotechnology (Fermentation) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Biotechnology (Fermentation) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Biotechnology (PCR Technology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Biotechnology (PCR Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Biotechnology (Chromatography) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Biotechnology (Chromatography) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Biotechnology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Biotechnology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Biotechnology (Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Biotechnology (Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Global: Biotechnology (Food and Agriculture) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Global: Biotechnology (Food and Agriculture) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Global: Biotechnology (Natural Resources and Environment) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Global: Biotechnology (Natural Resources and Environment) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Global: Biotechnology (Industrial Processing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Global: Biotechnology (Industrial Processing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Global: Biotechnology (Bioinformatics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Global: Biotechnology (Bioinformatics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Global: Biotechnology (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Global: Biotechnology (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: North America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: North America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: United States: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: United States: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Canada: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Canada: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Asia-Pacific: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Asia-Pacific: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: China: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: China: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Japan: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Japan: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: India: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: India: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: South Korea: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: South Korea: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Australia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Australia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Indonesia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Indonesia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Europe: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Europe: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Germany: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Germany: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: France: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: France: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: United Kingdom: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: United Kingdom: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Italy: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Italy: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Spain: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Spain: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Russia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Russia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 80: Latin America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 81: Latin America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 82: Brazil: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 83: Brazil: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 84: Mexico: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 85: Mexico: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 86: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 87: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 88: Middle East and Africa: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
- Figure 89: Middle East and Africa: Biotechnology Market: Breakup by Country (in %), 2024
- Figure 90: Middle East and Africa: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 91: Global: Biotechnology Industry: SWOT Analysis
- Figure 92: Global: Biotechnology Industry: Value Chain Analysis
- Figure 93: Global: Biotechnology Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Biotechnology Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Biotechnology Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
- Table 3: Global: Biotechnology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
- Table 4: Global: Biotechnology Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 5: Global: Biotechnology Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Biotechnology Market: Competitive Structure
- Table 7: Global: Biotechnology Market: Key Players
